A9610 Insurance Policy Changes

HCPCS A9610 is officially defined as "Xenon xe-129 hyperpolarized gas, diagnostic, per study dose." HCPCS A9610 is referenced in 2 tracked payer policy changes from BCBS Arizona and Aetna. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS A9610 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Only a small number of policies match this filter. Check back as coverage expands.

Related

All billing codesJ3590C9399J3490992139921499212

Get alerts for changes like this

Save a search and receive a daily digest whenever a new policy change matches your filters.

Create a free alert